-
Nature: Neuroscientist Lihui Cai reveals that APOE4 impairs the formation of myelin sheaths and causes cognitive dysfunction
Time of Update: 2023-01-06
1038/s41586-022-05439-wThe images in the article are from referencesthat this increase in cholesterol and lipid droplets was cell-specific: the increase was more pronouncedFigure 2: Expression of APOE4 in oligodendrocytes causes impaired myelination.
-
Nature: Neuroscientist Lihui Cai reveals that APOE4 impairs the formation of myelin sheaths and causes cognitive dysfunction
Time of Update: 2023-01-06
1038/s41586-022-05439-wThe images in the article are from referencesthat this increase in cholesterol and lipid droplets was cell-specific: the increase was more pronouncedFigure 2: Expression of APOE4 in oligodendrocytes causes impaired myelination.
-
Blood-friendly new students live up to the new chapter of Shaohuapu and look forward to the future, and the Hemophilia Frontier Progress Tour (Anhui Station) ended successfully
Time of Update: 2022-11-01
In recent years, the continuous advent of innovative drugs or therapies has increasingly met the diversified clinical treatment needs of patients with hemophilia A. However, individual patient variabi
-
A new technique to reveal hidden genomes
Time of Update: 2022-09-09
Computational biologist Dr Sonia Chothani, a Duke-NUS Cardiovascular and Metabolic Disease (CVMD) program researcher and lead author of the study, explained: "We have a large portion of the 2% of the genome that is known to encode proteins.
-
European Radiolog: Deep Learning Improves Radiologists' Performance in CT Bone Metastasis Detection
Time of Update: 2022-08-19
Deep learning-based algorithm improved radiologists' performance in bone metastases detection on CT.
Deep learning-based algorithm improved radiologists' performance in bone metastases detection on CT.
Deep learning-based algorithm improved radiologists' performance in bone metastases detection on CT.
-
Eur Radiol: A powerful combination of deep learning and CESM for non-invasive histological analysis of breast cancer
Time of Update: 2022-08-12
Contrast-enhanced spectral breast imaging (CESM), also known as contrast-enhanced dual-energy breast imaging (CEDM), is an emerging imaging technique that uses intravenous iodinated contrast to assess neovascularization in breast lesions for further evaluation benign and malignant lesions .
-
Industrial isobutane (HC-600a) (3
Time of Update: 2021-11-29
01g, insert the sampler into the bottom of the electrolytic cell of the Coulometric Moisture Analyzer, open the liquid phase outlet valve of the sampling cylinder, and set the sampling rate to It is advisable that there is no dew condensation near the sampler [keep the rate at (2～3)g/min], and the injection volume is about 10g or adjust the injection volume appropriately according to the water content of the sample .
-
The application of the fungus team has made important progress in the genetic research of lentinus edodes population
Time of Update: 2021-10-10
Nanhu News Network (correspondent Shen Nan) Recently, a research team led by Professor Yinbing Bian from the School of Plant Science and Technology of our school used the population genomics method fo
-
Dimethyl malonate for industrial use (3
Time of Update: 2021-10-04
3. 1 Method summaryUsing phenolphthalein as an indicator, titrate the free acid content in the sample with a standard sodium hydroxide titration solution .
-
CRO track all-line surge Tag Pharmaceuticals, Kanglong into a 10% rise in the rise and stop of new drugs
Time of Update: 2021-01-25
CRO enterprises are divided into preclinical CRO and clinical trial CRO two major categories, the current preclinical CRO is mainly engaged in compound research services and preclinical research services, including research, pilot compounds and active drug intermediate synthesis and process development, domestic and foreign companies are mainly Charles River, Covance (has been acquired by LabCorp), Syneos, Pharmaceutical Mingkangde (Apptec), Zhao yanxin pharmaceutical (Joinn Lab), Kanglong.
-
Noshingjian Obutini has been approved by the FDA to conduct a phase II study on the treatment of MS
Time of Update: 2020-11-04
MS is an autoimmune central nervous system disease in which the patient's immune system abnormally attacks the myelin around nerve cells, causing inflammation and tissue damage that disrupts the normal functioning of the brain, optic nerve and spinal cord.
-
Better than Xalkori! Beida Pharmaceuticals ALK inhibitor NSCLC Phase III clinical reached the main endpoint
Time of Update: 2020-08-12
results showed that the median progression-free survival (mPFS) in patients treated with Ensatinib for ALK-positive non-small cell lung cancer (NSCLC) was significantly longer than in patients treated with cratinib and reached the primary endpoint.
